These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 16076032)

  • 21. A novel BMT technique for treatment of various currently intractable diseases.
    Ikehara S
    Best Pract Res Clin Haematol; 2011 Sep; 24(3):477-83. PubMed ID: 21925101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevention of graft-versus-host disease by intrabone marrow injection of donor T cells: involvement of bone marrow stromal cells.
    Miyake T; Inaba M; Fukui J; Ueda Y; Hosaka N; Kamiyama Y; Ikehara S
    Clin Exp Immunol; 2008 Apr; 152(1):153-62. PubMed ID: 18307515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synergistic effects of injection of bone marrow cells into both portal vein and bone marrow on tolerance induction in transplantation of allogeneic pancreatic islets.
    Ikebukuro K; Adachi Y; Suzuki Y; Iwasaki M; Nakano K; Koike Y; Mukaide H; Yamada Y; Fujimoto S; Seino Y; Oyaizu H; Shigematsu A; Kiriyama N; Hamada Y; Kamiyama Y; Ikehara S
    Bone Marrow Transplant; 2006 Nov; 38(10):657-64. PubMed ID: 17013428
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogeneic intrabone marrow-bone marrow transplantation plus donor lymphocyte infusion suppresses growth of colon cancer cells implanted in skin and liver of rats.
    Koike Y; Adachi Y; Suzuki Y; Iwasaki M; Koike-Kiriyama N; Minamino K; Nakano K; Mukaide H; Shigematsu A; Kiyozuka Y; Tubura A; Kamiyama Y; Ikehara S
    Stem Cells; 2007 Feb; 25(2):385-91. PubMed ID: 17284650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allogeneic intra-BM-BMT plus adult thymus transplantation from same donor has benefits for long-term survival even after sublethal irradiation or low-dose BM cell injection.
    Nishida T; Hosaka N; Takaki T; Miyake T; Cui W; Inaba M; Kinoshita H; Matsuda T; Ikehara S
    Bone Marrow Transplant; 2009 Jun; 43(11):829-37. PubMed ID: 19079314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.
    Westerhof GR; Ploemacher RE; Boudewijn A; Blokland I; Dillingh JH; McGown AT; Hadfield JA; Dawson MJ; Down JD
    Cancer Res; 2000 Oct; 60(19):5470-8. PubMed ID: 11034090
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention of senile osteoporosis in SAMP6 mice by intrabone marrow injection of allogeneic bone marrow cells.
    Ichioka N; Inaba M; Kushida T; Esumi T; Takahara K; Inaba K; Ogawa R; Iida H; Ikehara S
    Stem Cells; 2002; 20(6):542-51. PubMed ID: 12456962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A new bone marrow transplantation method for stem cell disorders.
    Ikehara S
    Ann N Y Acad Sci; 2009 Sep; 1173():774-80. PubMed ID: 19758228
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New strategies for allogeneic BMT.
    Ikehara S
    Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S73-5. PubMed ID: 12931248
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recovery from established graft-vs-host disease achieved by bone marrow transplantation from a third-party allogeneic donor.
    Taniguchi Y; Yoshihara S; Hoshida Y; Inoue T; Fujioka T; Ikegame K; Kawakami M; Masuda T; Aozasa K; Kawase I; Ogawa H
    Exp Hematol; 2008 Sep; 36(9):1216-25. PubMed ID: 18599183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective graft-versus-leukemia effects independent of graft-versus-host disease after T cell-depleted allogeneic bone marrow transplantation in a murine model of B cell leukemia/lymphoma. Role of cell therapy and recombinant IL-2.
    Weiss L; Lubin I; Factorowich I; Lapidot Z; Reich S; Reisner Y; Slavin S
    J Immunol; 1994 Sep; 153(6):2562-7. PubMed ID: 8077666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Treatment of senile osteoporosis in SAMP6 mice by intra-bone marrow injection of allogeneic bone marrow cells.
    Takada K; Inaba M; Ichioka N; Ueda Y; Taira M; Baba S; Mizokami T; Wang X; Hisha H; Iida H; Ikehara S
    Stem Cells; 2006 Feb; 24(2):399-405. PubMed ID: 16109754
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Donor-origin cell engraftment after intraosseous or intravenous bone marrow transplantation in a rat model.
    Klimczak A; Unal S; Jankowska A; Coburn C; Siemionow M
    Bone Marrow Transplant; 2007 Aug; 40(4):373-80. PubMed ID: 17572707
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic intra-bone marrow transplantation prevents rheumatoid arthritis in SKG/Jcl mice.
    Kushida T; Ueda Y; Umeda M; Oe K; Okamoto N; Iida H; Abraham NG; Gershwin ME; Ikehara S
    J Autoimmun; 2009; 32(3-4):216-22. PubMed ID: 19349145
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term donor-specific tolerance in rat cardiac allografts by intrabone marrow injection of donor bone marrow cells.
    Guo K; Inaba M; Li M; An J; Cui W; Song C; Wang J; Cui Y; Sakaguchi Y; Tsuda M; Omae M; Ando Y; Li Q; Wang X; Feng W; Ikehara S
    Transplantation; 2008 Jan; 85(1):93-101. PubMed ID: 18192918
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intra-bone marrow injection of allogeneic bone marrow cells: a powerful new strategy for treatment of intractable autoimmune diseases in MRL/lpr mice.
    Kushida T; Inaba M; Hisha H; Ichioka N; Esumi T; Ogawa R; Iida H; Ikehara S
    Blood; 2001 May; 97(10):3292-9. PubMed ID: 11342461
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Comparison of efficacies of allogeneic hematopoietic stem cell transplantations between different routes of administration in mice].
    Cai Y; Huang SL; Huang K; Chen HQ; Zhang XC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Oct; 15(5):998-1004. PubMed ID: 17956678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amotosalen-treated donor T cells have polyclonal antigen-specific long-term function without graft-versus-host disease after allogeneic bone marrow transplantation.
    Hossain MS; Roback JD; Lezhava L; Hillyer CD; Waller EK
    Biol Blood Marrow Transplant; 2005 Mar; 11(3):169-80. PubMed ID: 15744235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.